BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

784 related articles for article (PubMed ID: 11689702)

  • 1. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.
    Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ
    Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloproliferative disorder FOP-FGFR1 fusion kinase recruits phosphoinositide-3 kinase and phospholipase Cgamma at the centrosome.
    Lelièvre H; Chevrier V; Tassin AM; Birnbaum D
    Mol Cancer; 2008 Apr; 7():30. PubMed ID: 18412956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1.
    Popovici C; Zhang B; Grégoire MJ; Jonveaux P; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ
    Blood; 1999 Feb; 93(4):1381-9. PubMed ID: 9949182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice.
    Guasch G; Delaval B; Arnoulet C; Xie MJ; Xerri L; Sainty D; Birnbaum D; Pébusque MJ
    Blood; 2004 Jan; 103(1):309-12. PubMed ID: 12969958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.
    Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ
    Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
    Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12].
    Pébusque MJ; Chaffanet M; Popovici C; Birnbaum D
    Bull Cancer; 2000 Dec; 87(12):887-94. PubMed ID: 11174118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downstream effectors of oncogenic ras in multiple myeloma cells.
    Hu L; Shi Y; Hsu JH; Gera J; Van Ness B; Lichtenstein A
    Blood; 2003 Apr; 101(8):3126-35. PubMed ID: 12515720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.
    Roumiantsev S; Krause DS; Neumann CA; Dimitri CA; Asiedu F; Cross NC; Van Etten RA
    Cancer Cell; 2004 Mar; 5(3):287-98. PubMed ID: 15050920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins.
    Demiroglu A; Steer EJ; Heath C; Taylor K; Bentley M; Allen SL; Koduru P; Brody JP; Hawson G; Rodwell R; Doody ML; Carnicero F; Reiter A; Goldman JM; Melo JV; Cross NC
    Blood; 2001 Dec; 98(13):3778-83. PubMed ID: 11739186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells.
    Dong S; Kang S; Gu TL; Kardar S; Fu H; Lonial S; Khoury HJ; Khuri F; Chen J
    Blood; 2007 Jul; 110(1):360-9. PubMed ID: 17389761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathways.
    Kanie T; Abe A; Matsuda T; Kuno Y; Towatari M; Yamamoto T; Saito H; Emi N; Naoe T
    Leukemia; 2004 Mar; 18(3):548-55. PubMed ID: 14749700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic tyrosine kinase of malignant hemopathy targets the centrosome.
    Delaval B; Létard S; Lelièvre H; Chevrier V; Daviet L; Dubreuil P; Birnbaum D
    Cancer Res; 2005 Aug; 65(16):7231-40. PubMed ID: 16103074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.
    Chen J; Deangelo DJ; Kutok JL; Williams IR; Lee BH; Wadleigh M; Duclos N; Cohen S; Adelsperger J; Okabe R; Coburn A; Galinsky I; Huntly B; Cohen PS; Meyer T; Fabbro D; Roesel J; Banerji L; Griffin JD; Xiao S; Fletcher JA; Stone RM; Gilliland DG
    Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14479-84. PubMed ID: 15448205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33).
    Guasch G; Mack GJ; Popovici C; Dastugue N; Birnbaum D; Rattner JB; Pébusque MJ
    Blood; 2000 Mar; 95(5):1788-96. PubMed ID: 10688839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5.
    Smedley D; Demiroglu A; Abdul-Rauf M; Heath C; Cooper C; Shipley J; Cross NC
    Neoplasia; 1999 Oct; 1(4):349-55. PubMed ID: 10935490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3).
    Guasch G; Popovici C; Mugneret F; Chaffanet M; Pontarotti P; Birnbaum D; Pébusque MJ
    Blood; 2003 Jan; 101(1):286-8. PubMed ID: 12393597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases.
    Vizmanos JL; Hernández R; Vidal MJ; Larráyoz MJ; Odero MD; Marín J; Ardanaz MT; Calasanz MJ; Cross NC
    Hematol J; 2004; 5(6):534-7. PubMed ID: 15570299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction pathways triggered by fibroblast growth factor receptor 1 expressed in Xenopus laevis oocytes after fibroblast growth factor 1 addition. Role of Grb2, phosphatidylinositol 3-kinase, Src tyrosine kinase, and phospholipase Cgamma.
    Browaeys-Poly E; Cailliau K; Vilain JP
    Eur J Biochem; 2000 Oct; 267(20):6256-63. PubMed ID: 11012680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia.
    Liu Q; Schwaller J; Kutok J; Cain D; Aster JC; Williams IR; Gilliland DG
    EMBO J; 2000 Apr; 19(8):1827-38. PubMed ID: 10775267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.